Screening for Pancreatic Cancer
Open accessAbstract
Nora B. Henrikson, PhD, MPH; Erin J. Aiello Bowles, MPH; Paula R. Blasi, MPH; Caitlin C. Morrison, MPH; Matt Nguyen, MPH; Venu G. Pillarisetty, MD; Jennifer S. Lin, MD, MCR
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In 2019, the US Preventative Services Task Force recommended against pancreas screening of asymptomatic average-risk adults and those with a family history, but it did not address the role of surveillance in germline mutation carriers.
“In 2019, the US Preventative Services Task Force recommended against pancreas screening of asymptomatic average-risk adults and those with a family history, but it did not address the role of surveillance in germline mutation carriers.12,13”
From The Multicenter Cancer of Pancreas Screening Study: Impact on Stage and Survival (2022) · cites this paper as [13]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
The citation lists haven’t been fetched yet
References 16 · Cited by 52
Research works printed but not linked: 1
- Konings ICAW, Canto M, Almario JA, et al. Detection and outcome of pancreatic cancer surveillance in high-risk individuals: results from the CAPS Consortium [published online July 2, 2019]. BJS Open. doi:10.1002/bjs5.50180 · DOI
- Authors
- Lucas, A. L., & Kastrinos, F.
- Affiliations
- Icahn School of Medicine at Mount Sinai (US)
- Columbia University Irving Medical Center (US)
- Corresponding author
- Lucas, Aimee L.
- Venue
- JAMA
- Publisher
- American Medical Association (AMA)
- Published
- 2019-08-06
- Volume
- 322
- Issue
- 5
- Pages
- 407
- ISSN
- 0002-9955 (ISSN-L)
- 0098-7484
- OpenAlex
- W2964883846
- Cited by
- 52
- References
- 16
- Citations by year
- 2026: 3 · 2025: 9 · 2024: 9 · 2023: 10 · 2022: 11 · 2021: 7 · 2020: 3
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- JAMA (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Oncology › Pancreatic and Hepatic Oncology Research
- Health Sciences › Medicine › Oncology › Global Cancer Incidence and Screening
- Health Sciences › Medicine › Surgery › Pancreatitis Pathology and Treatment
- Keywords
- pancreatic cancer, cancer screening, early detection
- MeSH terms
- Humans, Mass Screening, Pancreas, Pancreatic Neoplasms, Early Detection of Cancer
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
